Immatics N.V. Ordinary Shares — Grafico, Quotazione e Notizie (NASDAQ:IMTX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 15.43 M
Employee 407
Founded 2000
CEO Harpreet Singh
Website www.immatics.com
Headquarter Netherlands
FIGI N/A
Industry Biotecnologia

Notizie

Gli EPS di Immatics NV hanno mancato le aspettative per 0,04€, il fatturato appena sotto le previsioni

Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates

TD Cowen avvia la copertura di Immatics con rating buy

Immatics annuncia quattro presentazioni orali al meeting ASCO

Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)